Some NADH-linked aspartate aminotransferase (AST) assay systems may produce significant errors due to endogenous pyruvate because the pre-incubation time employed is too short and/or because the reagent lactate dehydrogenase (LD) activity is inadequate. Such errors in patient specimens may go unnoticed if quality control materials themselves contain a low pyruvate concentration.
A theory of pyruvate interference in AST assay is formulated and calculation programs are described which will allow a laboratory to assess whether their particular AST methods are likely to be subject to such interference and also to predict a way of removing any error thus identified.
RodgersonDOOsbergIM. Sources of error in spectrophotometric measurement of aspartate aminotransferase and alanine aminotransferase activities in serum. Clin Chem1974; 20, 43–50.
2.
BianchessiM.Estimation of blood pyruvic acid in liver diseases and in pancreatic diabetes. Clin Chim Acta1958; 3: 179–82.
3.
SinghSVGoyalSKChowdhuryBLGuptaVB. A study of blood pyruvic acid and lactic acid levels in acute myocardial infarction. J Assoc Physicians India1973; 21: 411–14.
4.
JonesEABerkPD. Liver Function. In: BrownSSMitchellFLYoungDS, eds. Chemical Diagnosis of Disease. Oxford: Elsevier, 1979; 635–66.
5.
GuderWGWahlefeldAW. Specimens and samples in clinical laboratory sciences. In: BergmeyerHU, ed. Methods of Enzymatic Analysis. vol 2, 3rd Edn.Weinheim: Verlag Chemie, 1983; 2–20.
6.
DavidsonDFWilliamsonJBoagDE. Pyruvate interference in aminotransferase assay — the importance of close control of reagent pH. Ann Clin Biochem1989; 26: 447–8.
7.
Van ZantenAPVerbeekKA. Pyruvate interference in RA 1000 single-reagent AST method. Clin Chem1984; 30: 1883.
8.
LustigVPapanastasiou-DiamandisAGoldbergDM. Evaluation of commercially formulated aspartate aminotransferase and alanine aminotransferase activity determinations by the Scandinavian Committee on Enzyme and IFCC methods as modified for use with automated enzyme analysers. Clin Biochem1988; 21: 283–90.
9.
MossD.The standardisation of enzyme activity measurements. Ann Clin Biochem1988; 25: 1–3.
BergmeyerHUSchiebePWahlefeldAW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem1978; 24: 58–73.
12.
SchwertGWMillerBRPeanaskyRJ. Lactic Dehydrogenase. X. A re-evalulation of the effects of pH upon the kinetics of the reaction. J Biol Chem1967; 242: 3245–52.
13.
AtwoodJGDiCesareJL. Making enzymatic methods optimum for measuring compounds with a kinetics analyser. Clin Chem1975; 21: 1263–9.
14.
KellerFEmdeCSchwarzA.Exponential function for saturable enzyme kinetics. Clin Chem1988; 34: 2486–9.
Expert Panel on Enzymes. Committee on Standards (IFCC): Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes; part 2. IFCC method for aspartate aminotransferase. Clin Chem1977; 23, 887–99.
20.
McCombRBBondLWBurnettRWKeechRCBowersGN. Determination of the molar absorptivity of NADH. Clin Chem1976; 22: 141–50.
21.
ZiegenhornJSennMBucherT.Molar absorptivities of β-NADH and β-NADPH. Clin Chem1976; 22: 151–60.
22.
ReynoldsCHLeeflangPIlemobadeAABuysJ.Assay of serum enzymes in trypanosomal infection: Interference by pyruvate. Trans R Soc Trop Med Hyg1973; 67: 429–30.
23.
DaltonRN. The effect of pyruvate on the enzymic measurement of plasma ammonia. Ann Clin Biochem1987; 24: Suppl. 216.
24.
WilkinsonJHWalterSJ. Oxamate as a differential inhibitor of lactate dehydrogenase isoenzymes. Enzyme1972; 13: 170–6.
25.
LustigVRedmanLW. Improved serum-initiated aspartate aminotransferase assay by inhibition of lactate dehydrogenase with oxamate. Clin Chem1980; 26: 831–4.
